Pain syndrome in urology: features of classification and pathogenetic aspects

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Key aspects of pain syndrome in urology, including its classification, pathogenesis, and current treatment approaches, are discussed in the article. Special attention is given to the phenomenon of chronic pelvic pain, defined as persistent pain lasting at least three months, accompanied by dysfunction of the genitourinary system and emotional disorders.

The main pathogenetic mechanisms underlying pain syndrome determine its complex multisystem nature, which requires a comprehensive approach to both diagnosis and treatment. Various etiologies of urologic chronic pain syndrome are described. Particular emphasis is given on urological causes such as bacterial cystitis and interstitial cystitis/bladder pain syndrome (IC/BPS). Clinical phenotypes of IC/BPS are discussed, along with individualized treatment approaches for each phenotype. The impact of pain syndrome in bacterial cystitis on quality of life and the role of phenazopyridine in pain relief are also highlighted.

The importance of an interdisciplinary approach and the combination of different therapeutic methods to achieve good outcomes in the management of pain syndrome is emphasized.

Full Text

Restricted Access

About the authors

Olga A. Plekhanova

S.P. Botkin Moscow Multidisciplinary Clinical and Research Center; Rosbiotech University

Author for correspondence.
Email: oll_e@mail.ru
ORCID iD: 0000-0002-9410-3371

urologist, Senior Lecturer, Department of Urology

Russian Federation, Moscow; Moscow

Dmitry Y. Pushkar

S.P. Botkin Moscow Multidisciplinary Clinical and Research Center; FGBOU VO “Russian University of Medicine”, Ministry of Health of the Russian Federation

Email: pushkardm@mail.ru
ORCID iD: 0000-0002-6096-5723

academician of RAS, Ph.D., MD, Professor, Chief urologist of the Ministry of Health of Russia, Chief urologist of the Moscow Health Department, Chief, Head of the Department of Urology

Russian Federation, Moscow; Moscow

References

  1. Kasyan G.R., Zaitsev A.V., Bagateliya Z.A. et al. Pain management in urology: Methodological recommendations. Moscow: MedINK Publishing, 2025. 40 p. Russian (Обезболивание в урологии: Методические рекомендации / Г.Р. Касян, А.В. Зайцев, З.А. Багателия и др. М.: ИД «МедИНК», 2025. 40 с.)
  2. Davydov O.S. Chronification of pain: risk factors, mechanisms and possibilities for prevention. Lechashchiy Vrach. 2017;5:6–10. Russian (Давыдов О.С. Хронизация боли: факторы риска, механизмы и возможности предупреждения. Лечащий врач. 2017;5:6–10).
  3. James Smith, Lenny Ng. The management of acute pain – an update. Medicine. 2025;53(2):102–108.
  4. EAU Guidelines. Edn. presented at the EAU Annual Congress, Madrid 2025. ISBN 978-94-92671-29-5.
  5. Marganne M-H. John F Nunn, Ancient Egyptian medicine, London, British Museum Press, 1996, pp. 240, illus. Medical History. 1997;41(3):410–411.
  6. Tashani OA, Johnson MI. Avicenna’s concept of pain. Libyan J Med. 2010 Sep 8;5. doi: 10.3402/ljm.v5i0.5253. PMID: 21483573; PMCID: PMC3066781
  7. Hunner GL. Neurosis of the bladder. J Urol. 1930;24:567-585.
  8. Su PP, Zhang L, He L, Zhao N, Guan Z. The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice. J Pain Res. 2022 Aug 4;15:2223-2248. doi: 10.2147/JPR.S246883. PMID: 35957964; PMCID: PMC9359791
  9. Divya Gupta, Chandan Kumar. Autonomic Dysfunction in Women with Chronic Pelvic Pain: A Heart Rate Variability-Based Cross-Sectional Study from an Indian Tertiary Care Center. Research Article. 2025;15(1).
  10. Yoshikawa S, Kawamorita N, Oguchi T, Funahashi Y, Tyagi P, Chancellor MB, Yoshimura N. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience. 2015;284:422–429. doi: 10.1016/j.neuroscience.2014.08.064. Epub 2014 Oct 15. PMID: 25445197
  11. Chronic pelvic pain. Belova A.I., Krupin V.N. (eds). Moscow: Antidor, 2007. 572 p. Russian (Хроническая тазовая боль: под ред. Беловой А.И., Крупина В.Н. М.: Антидор, 2007. 572 с.).
  12. Zaitsev A.V., Kasyan G.R., Spivak L.G. Cystitis. Urologiia. 2017;1(Suppl. 1):34–44. Russian (Зайцев А.В., Касян Г.Р., Спивак Л.Г. Цистит. Урология. 2017;1(Прил. 1):34–44).
  13. Ministry of Health of Russia. Clinical guidelines «Cystitis in women», 2024. Available at: https://cr.minzdrav.gov.ru/view-cr/14_3. Russian (Клинические рекомендации Минздрава России «Цистит у женщин», год утв. 2024 https://cr.minzdrav.gov.ru/view-cr/14_3).
  14. Hoffman A, Dolezal KA, Powell R. Dysuria: Evaluation and Differential Diagnosis in Adults. Am Fam Physician. 2025;111(1):37–46. PMID: 39823614.
  15. Gadzhieva Z.K. Diagnostic and treatment features of recurrent lower urinary tract infections. Urologiia. 2013;3:84–90. Russian (Гаджиева З.К. Особенности подхода к диагностике и лечению рецидивирующих инфекций нижних мочевыводящих путей. Урология. 2013;3:84–90).
  16. Rafalsky V.V., Moiseeva E.M. Epidemiology of uncomplicated community-acquired urinary tract infections in the Russian Federation. Vestnik Urologii. 2018;6(2):30–37. Russian (Рафальский В.В., Моисеева Е.М. Эпидемиология неосложненных внебольничных инфекций мочевыводящих путей в Российской Федерации. Вестник урологии. 2018;6(2):30–37).
  17. Slesarevskaya M.N., Ignashov Yu.A., Kuzmin I.V., Al-Shukri S.Kh. Persistent dysuria in women: etiological diagnosis and treatment. Urologicheskiye vedomosti. 2021;11(3):195–204. Russian (Слесаревская М.Н., Игнашов Ю.А., Кузьмин И.В., Аль-Шукри С.Х. Стойкая дизурия у женщин: этиологическая диагностика и лечение. Урологические ведомости. 2021;11(3):195–204).
  18. General characteristics of the medicinal product Urinalgin F, Registration Certificate No. (005800)-(RG-RU). Russian (Общая характеристика лекарственного препарата Уриналгин Ф, РУ ЛП-№(005800)-(РГ-RU)).
  19. Shireen N. Farzadeh et al. Urinary Tract Infections and Self-Care Options, US Pharm. 2017;9(42):4–7.
  20. Aizawa N, Wyndaele JJ. Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen. Neurourol Urodyn. 2010;29(8):1445–50. doi: 10.1002/nau.20886. PMID: 20976818.
  21. Nickel JC. Managing interstitial cystitis/bladder pain syndrome in female patients: Clinical recipes for success. Can Urol Assoc J. 2022;16(12):393–398. doi: 10.5489/cuaj.8055. PMID: 36656690; PMCID: PMC9851219

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Bionika Media